|
| | DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Basic information |
| Product Name: | DIHYDROERGOTAMINE TARTRATE CRYSTALLINE | | Synonyms: | 9,10-dihydroergotaminetartrate;dihydro-ergotamintartrate(2:1)(salt);bis[5'alpha-benzyl-9,10alpha-dihydro-12'-hydroxy-2'-methylergotaman-3',6',18-trione] [R-(R*,R*)]-tartrate;DIHYDROERGOTAMINETARTRATE[DD];Dihydroergotamintartrat;DIHYDROERGOTAMINE TARTRATE CRYSTALLINE;Dihydroergotamine tartrate (D1952000) | | CAS: | 5989-77-5 | | MF: | 2C33H37N5O5.C4H6O6 | | MW: | 1317.46 | | EINECS: | 227-816-1 | | Product Categories: | Alkaloids;Biochemistry;Indole Alkaloids | | Mol File: | 5989-77-5.mol |  |
| | DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Chemical Properties |
| Melting point | 205 °C (decomp)(Solv: methanol, 95% (67-56-1)) | | refractive index | -55 ° (C=1, Pyridine) | | solubility | Very slightly soluble in water, sparingly soluble in alcohol | | form | neat |
| Hazard Codes | Xn | | Risk Statements | 20/21/22 | | Safety Statements | 36 | | RIDADR | 1544 | | WGK Germany | 3 | | RTECS | KE8000000 | | HazardClass | 6.1(b) | | PackingGroup | III |
| | DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Usage And Synthesis |
| Chemical Properties | White or almost white, crystalline powder or colourless crystals. | | Uses | Dihydroergotamine (+)-tartrate salt is a vascular serotonin receptor activator. In addition, it has been shown to induce lung cancer cell death through apoptosis and mitophagy. | | Uses | Antimigraine;Serotonine antagonist | | Definition | ChEBI: The L-(+)-tartaric acid salt of dihydroergotamine, a semisynthetic ergot alkaloid with weaker oxytocic and vasoconstrictor properties than ergotamine. Both the tartrate and the mesylate salts are used for the treatment of migraine and orth
static hypotension. |
| | DIHYDROERGOTAMINE TARTRATE CRYSTALLINE Preparation Products And Raw materials |
|
